Armistice Capital, LLC 13D and 13G filings for Citius Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 6:44 pm Sale | 2021-12-31 | 13G | Citius Pharmaceuticals, Inc. CTXR | Armistice Capital, LLC | 97,000 1.600% | -149,734 (-60.69%) | Filing |
| 2021-02-16 3:00 pm Purchase | 2020-12-31 | 13G | Citius Pharmaceuticals, Inc. CTXR | Armistice Capital, LLC | 246,734 9.990% | 118,297 (+92.11%) | Filing |